International Publisher of Science, Technology and Medicine

 
 
Share this
 
 
 
Track Your Manuscript
 
 
 
 
International Journal of Cardiovascular Research
Editor-in-chief: Jimmy T Efird, PhD
East Carolina University, USA   Editorial Board
ISSN: 2324-8602
Frequency: Bimonthly
 
International Journal of Cardiovascular Research is a peer-reviewed scholarly journal and aims to publish the most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of cardiology and making them available online freely without any restrictions or any other subscriptions to researchers worldwide.
 
International Journal of Cardiovascular Research focuses on the topics include Heart diseases, Cardiovascular medicine, Echocardiography, Cardiac electrophysiology, Neuro cardiology, Cardiac Anesthesiology, Disorders of heart, treatment, pediatric cardiology, Interventional Cardiology and Hypercholesterolemia.
 
The journal is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of International Journal of Cardiovascular Research or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.
 
Submit manuscript at http://www.editorialmanager.com/scitechnol/ or send as an e-mail attachment to the Editorial Office at editor.icrj@scitechnol.com or editor.icrj@scitechnol.org
 
International Journal of Cardiovascular Research is organizing & supporting 5th International Conference on Clinical & Experimental Cardiology during April 27-29, 2015 Philadelphia, USA with the theme of Blooming landscapes in cardio research.
 
Current Issue
Editors & Editorial Board Members  
Int J Cardiovasc Res 2013, 3:1   
  PDF   
Specificity of the Cardiocerebral-Event Reductions in the Kyoto Heart and Jikei Heart Study   Commentary
Hisato Takagi and Takuya Umemoto
Int J Cardiovasc Res 2014, 3:1    doi: 10.4172/2324-8602.1000156
 Preview

Specificity of the Cardiocerebral-Event Reductions in the Kyoto Heart and Jikei Heart Study

The Kyoto Heart Study was a prospective randomized open blinded end-point (PROBE)-design trial, in which 3031 Japanese patients (mean, 66 years) with uncontrolled hypertension were randomized to either valsartan add-on or non-angiotensin receptor blocker (ARB) treatment.

|  Full Text |   PDF   
Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage   Research Article
Vladimir I Morozov, Michael I Kalinski, Jason Jaggers, Nikolay V Goncharov and Galina A Sakuta
Int J Cardiovasc Res 2014, 3:1    doi: 10.4172/2324-8602.1000157
 Preview

Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage

This is an overview of literature data on ischemia-modified albumin (IMA) and its potential as a marker of myocardium and skeletal muscle damage. Characteristics and properties of IMA are considered. IMA can be used as a nonspecific variable of ischemic conditions but IMA fails to differentiate between ischemic tissues. As a marker of ischemic conditions IMA may be used in combinations with other markers.

|  Full Text |   PDF   
Left Atrial Myxoma Associated with Advanced Atrioventricular Block in a Very Elderly Woman   Case Report
Elia De Maria, Lorenzo Bonetti, Alina Olaru and Stefano Cappelli
Int J Cardiovasc Res 2014, 3:1    doi: 10.4172/2324-8602.1000158
 Preview

Left Atrial Myxoma Associated with Advanced Atrioventricular Block in a Very Elderly Woman

Primary cardiac tumors are rare and only 10% of them are malignant. Nearly 80% of benign forms are myxomas that usually develop in the atria, 75% originating in the left atrium and 15-20% in the right atrium.

|  Full Text |   PDF   
Amiodarone-Induced Life- Threatening Ventricular Arrhythmias in a Patient with Cerebrogenic QT Interval Prolongation. Clinical Implications   Case Report
Vincenzo Marafioti, Vincenzo Carbone and Giuseppe Oreto
Int J Cardiovasc Res 2014, 3:1    doi: 10.4172/2324-8602.1000159
 Preview

Amiodarone-Induced Life- Threatening Ventricular Arrhythmias in a Patient with Cerebrogenic QT Interval Prolongation. Clinical Implications

Acquired causes of abnormal QT interval prolongation include drug effect, toxins, electrolyte imbalance, hypothermia, severe bradyarrhythmias, myocardial ischemia, heart failure, altered nutritional states, hypothyroidism, Coxsackie B3 myocarditis, immunodeficiency virus syndrome.

|  Full Text |   PDF